Year: 2024
Type: article
Abstract: In order to ensure regulated administration of various medications with predetermined release profiles, bi-layer tablets have been developed. The pharmaceutical industry has become more interested in creating a bilayer tablet, which combines two or more Active Pharmaceutical Ingredients (API), in a single dose form over the past ten years in an effort to improve patient convenience and compliance. Bi-layer tablets can be used for the sequential release of two medications together, to separate two substances that are incompatible, or for sustained release tablets where the first layer is an immediate release dose and the second layer is a maintenance dose. A bilayer tablet is an enhanced, useful technology that addresses the shortcomings of a single-layered tablet.Currently, a number of pharmaceutical companies are working on creating bi-layer tablets. for a number of reasons, including marketing, therapeutics, and patent extensions. Such tablets are frequently developed and produced using modified but already-existing tablet presses in order to minimize capital investment.
Author: Mohammad Khalid
Language: English
Subfield: Pharmaceutical Science
Domain: Life Sciences
Open Access status: diamond
OpenAlex ID: W4405650766